KEYTRUDA® (pembrolizumab): Risk of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)
Date: 11 May 2017 Description: Cases of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported internationally in patients treated with Keytruda® (pembrolizumab) in…